Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
很抱歉, 生成此内容时发生错误。

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号